As of 30 Sep 2025, 21 institutional investors reported holding $345,063,000 in principal (par value) of NEOGENOMICS INC - NOTE 0.250% 1/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $11,000 | $985,000 | 8954.55% | 1 | |
| 2025 Q3 | $345,063,000 | $300,247,353 | -$1,047,258 | 86.5% | 21 |
| 2025 Q2 | $347,424,500 | $298,701,017 | +$1,329,076 | 85.38% | 24 |
| 2025 Q1 | $345,968,500 | $300,355,654 | +$507,793 | 86.32% | 24 |
| 2024 Q4 | $346,156,500 | $292,693,370 | -$7,990,591 | 84.0% | 27 |
| 2024 Q3 | $356,060,500 | $296,374,577 | +$17,437,220 | 82.86% | 28 |
| 2024 Q2 | $335,580,500 | $263,497,607 | +$1,308,070 | 78.17% | 28 |
| 2024 Q1 | $333,774,500 | $266,976,531 | +$1,456,937 | 79.75% | 25 |
| 2023 Q4 | $333,400,500 | $253,694,214 | +$3,165,777 | 75.6% | 30 |
| 2023 Q3 | $329,987,000 | $237,042,492 | -$556,393 | 71.53% | 28 |
| 2023 Q2 | $330,413,000 | $243,310,105 | -$296,237 | 73.32% | 32 |
| 2023 Q1 | $330,802,000 | $244,199,793 | +$1,969,797 | 73.51% | 30 |
| 2022 Q4 | $331,631,000 | $215,226,340 | +$776,251 | 64.63% | 33 |
| 2022 Q3 | $277,556,500 | $183,092,769 | -$26,084,301 | 64.64% | 31 |
| 2022 Q2 | $318,858,347 | $202,728,341 | +$10,098,000 | 62.13% | 30 |
| 2022 Q1 | $298,643,089 | $201,340,104 | -$2,525,738 | 66.57% | 36 |
| 2021 Q4 | $293,181,906 | $250,805,827 | -$23,948,051 | 85.41% | 31 |
| 2021 Q3 | $320,195,500 | $323,656,284 | +$11,107,101 | 101.13% | 33 |
| 2021 Q2 | $308,715,774 | $302,787,253 | +$10,622,528 | 97.62% | 29 |
| 2021 Q1 | $298,991,370 | $302,575,255 | +$302,575,255 | 101.11% | 38 |